Omitting hemicolectomy for patients with appendiceal neuroendocrine tumours of 1-2 cm

Lancet Oncol. 2023 May;24(5):e189. doi: 10.1016/S1470-2045(23)00122-5.

Authors

Thorvardur R Halfdanarson¹, Travis E Grotz², Hallbera Gudmundsdottir², Sean P Cleary²

Affiliations

¹ Division of Medical Oncology, Mayo Clinic, Rochester, MN 55905, USA. Electronic address: halfdanarson.thorvardur@mayo.edu.
² Department of Surgery, Mayo Clinic, Rochester, MN 55905, USA.

PMID: 37142377
DOI: 10.1016/S1470-2045(23)00122-5

No abstract available

Publication types

Letter
Comment

MeSH terms

Appendectomy / adverse effects
Appendiceal Neoplasms* / pathology
Appendiceal Neoplasms* / surgery
Colectomy / adverse effects
Humans
Neuroendocrine Tumors* / pathology
Neuroendocrine Tumors* / surgery
Patients
Retrospective Studies